<DOC>
	<DOCNO>NCT01487395</DOCNO>
	<brief_summary>The early assessment new drug Alzheimer 's disease remain difficult lack predictive end-point . The use battery include different parameter could improve early development new drug . Nevertheless , interest battery previously validate yet market AD drug</brief_summary>
	<brief_title>Prediction Cognitive Properties New Drug Candidates Neurodegenerative Diseases Early Clinical Development</brief_title>
	<detailed_description>The aim present study test effect 15-day treatment donepezil mixed battery associate cognitive assessment , image neurophysiological test healthy volunteer . This multicenter , randomize , placebo-controlled , cross-over study double-blind control conducted 3 center locate France ( Lille , Marseille Toulouse ) . 18-30 year old , healthy volunteer , without neurological psychiatric impairment , complete 2 test session randomize order : one 15-day treatment donepezil , placebo , submit mixed battery 14th 15th day treatment . The primary outcome study base cognitive assessment , image parameter neurophysiological parameter .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Neurodegenerative Diseases</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>1830 year old male nonsmoker subject Subject without cognitive impairment cognitive complaint ( Moca &gt; 26 , Mac Nair scale &lt; 15 ) Subject without history brain disease ( severe brain trauma , stroke , cerebral tumor , … ) Subject without major medical surgical history Subject without current chronic disease Subject without current cerebral disease Subject without vascular metabolic risk factor Subject without history current mental disease addiction ( MINI ) Subject without lesion MRI Subject without abnormal electrical activity EEG Subject without use chronic treatment psychotropic drug substance French speaker subject able understand test instruction Subject age &lt; 18 year &gt; 30 year Subject dementia cognitive decline identify Moca &lt; 26 Subject history brain disease ( brain trauma , stroke , cerebral tumor , … ) Subject major medical surgical history Subject current chronic disease Subject current cerebral disease Subject vascular metabolic risk factor Subject history current mental disease addiction Subject family history youngonset dementia Subject family history chronic severe neurological mental disease ( first degree relative ) Subject lesion MRI Subject abnormal electrical activity EEG Subject receive chronic treatment Subject use chronically acutely psychotropic drug substance Subject claustrophobia contraindication MRI Subject unable understand test instruction</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Alzheimer</keyword>
	<keyword>Donepezil</keyword>
	<keyword>biomarkers</keyword>
	<keyword>battery</keyword>
	<keyword>cognition</keyword>
	<keyword>image</keyword>
	<keyword>neurophysiological</keyword>
</DOC>